Newsletters

Alturas Advisor
Special Edition 2021
Celebrating 20 Years

Alturas Advisor
Fall/Winter 2019-20
The Bioanalyst: Challenges and Solutions

Alturas Advisor
Fall/Winter 2018-19
Discovery Platform for Cystine-Dense Peptides (CDP) Therapeutics Analysis by Microflow HPLC-MS/MS

Alturas Advisor
Fall/Winter 2017-18
Meet ALICE: Alturas Lab Interface Communications Equipment

Alturas Advisor
Fall/Winter 2016-17
A Better Diagnostic Test for Tuberculosis: GC-MS/MS Bioanalysis for the Determination of the Biomarker D-Arabinose in Urine

Alturas Advisor
Fall/Winter 2015-2016
Crystal City VI: Assay Criteria and Level of Validation Require for Biormarkers Will Depend Upon the Intended Purpose of the Assay

Alturas Advisor
Fall/Winter 2014-15
Expanding Bioanalytical & Biomarker Capabilities: Addition of TSQ Quantum XLS Ultra

Alturas Advisor
Fall/Winter 2013-14
Driving Innovation in Regulated Bioanalysis through Microflow Liquid Chromatography and High Flow Nanospray Mass Spectrometry

Alturas Advisor
Fall/Winter 2012-13
Micro Flow Liquid Chromatography (MFLC)-MS/MS Bioanalytical Research

Alturas Advisor
Fall/Winter 2011-12
LC-MS/MS Bioanalysis of Macromolecules: Proteins and Biomarkers

Alturas Advisor
Fall/Winter 2010-11
Research Advances with Dried Blood Spot Analysis (DBS) Coupled with LC/MS/MS

Alturas Advisor
Fall/Winter 2009-2010
Dried Blood Spot Analysis Coupled with LC/MS/MS

Alturas Advisor
Fall/Winter 2008-09
Bioanalysis: Are There Always Negative Consequences?

Alturas Advisor
Fall/Winter 2007-2008
HPLC/MS/MS Bioanalysis of Peptides